Fennec logo.jpg
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024
March 19, 2024 06:01 ET | Fennec Pharmaceuticals Inc.
RESEARCH TRIANGLE PARK, N.C., March 19, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the...
BEAM-Logo-Color and Black-Large-576x375.png
Beam Global Granted U.S. Patent for Wireless / Inductive Electric Vehicle Charging Powered by Renewable Energy
March 19, 2024 06:00 ET | Beam Global
Beam Global Granted U.S. Patent for Wireless / Inductive Electric Vehicle Charging Powered by Renewable Energy
crinetics.png
Crinetics’ Once-Daily Oral Paltusotine Achieved the Primary and All Secondary Endpoints in the Phase 3 PATHFNDR-2 Study in Acromegaly Patients
March 19, 2024 06:00 ET | Crinetics Pharmaceuticals, Inc.
56% of Participants on Paltusotine Achieved IGF-1 ≤1.0 xULN vs. 5% on Placebo (p<0.0001) Paltusotine was Generally Well-tolerated with No Serious Adverse Events Positive Topline Results...
Unknown.jpg
Opthea to Host Key Opinion Leader Event on Sozinibercept (OPT-302) in Wet Age-Related Macular Degeneration on April 3, 2024
March 19, 2024 06:00 ET | Opthea Limited
MELBOURNE, Australia and PRINCETON, N.J., March 19, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT; NASDAQ:OPT; “Opthea”), a clinical-stage biopharmaceutical company developing novel therapies to...
Fespa-Max-Plus
Kornit Digital Reveals New Opportunities for Brands and Retailers, Sportswear, Home Décor, and Screen Printers with Robust Showcase at FESPA Digital Print Expo 2024
March 19, 2024 05:00 ET | Kornit Digital Ltd
Retailers and brands embrace new Kornit Atlas MAX PLUS, reinforcing the highest standards of quality, reliability, vibrant color matching, and unwavering consistency Preview of “Max Transfer,”...
XORTX Logo.jpg
XORTX Highlights Achievements of 2023 and Preparation for Registration Clinical Trial
March 19, 2024 05:00 ET | XORTX Therapeutics Inc.
CALGARY, Alberta, March 19, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANUA WKN: A3UNZ), a late-stage clinical pharmaceutical...
pluri.jpg
Engage with Pluri's Talent: Exciting Conference Appearances Ahead
March 19, 2024 04:00 ET | Pluri Inc.
HAIFA, Israel, March 19, 2024 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq:PLUR) (TASE:PLUR) ("Pluri" or "the Company"), a leading biotechnology company that transforms cells into solutions that promote...
WISe.ART to Host the
WISe.ART to Host the Prestigious ProArte y Cultura Mayte Spínola Gold Medals 2023 at the Iconic Nasdaq Building in New York City on April 1, 2024
March 19, 2024 02:00 ET | Wisekey International Holding Ltd.
New York, NY & Madrid, Spain, March 19, 2024 (GLOBE NEWSWIRE) -- WISe.ART to Host the Prestigious ProArte y Cultura Mayte Spínola Gold Medals 2023 at the Iconic Nasdaq Building in New York City...
WISe.ART será el anf
WISe.ART será el anfitrión de las Prestigiosas Medallas de Oro Mayte Spínola 2023 del Grupo ProArte y Cultura en el icónico edificio Nasdaq en la ciudad de Nueva York 1 Abril 2024
March 19, 2024 02:00 ET | Wisekey International Holding Ltd.
New York, NY &b Madrid, Spain, March 19, 2024 (GLOBE NEWSWIRE) -- WISe.ART será el anfitrión de las Prestigiosas Medallas de Oro Mayte Spínola 2023 del Grupo ProArte y Cultura en el icónico...
Obseva Logo highresolution.jpg
ObsEva Announces Update on Board of Directors
March 19, 2024 02:00 ET | ObsEva SA
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – March 18, 2024 – ObsEva SA (SIX: OBSN), a biopharmaceutical company developing and commercializing novel...